Cargando…

PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients

Detalles Bibliográficos
Autores principales: Negro, G, Consolaro, A, Verazza, S, Bracciolini, G, Rosina, S, Pignataro, R, Civino, A, Martini, A, Ravelli, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043642/
http://dx.doi.org/10.1186/1546-0096-11-S2-P155
_version_ 1782318953449652224
author Negro, G
Consolaro, A
Verazza, S
Bracciolini, G
Rosina, S
Pignataro, R
Civino, A
Martini, A
Ravelli, A
author_facet Negro, G
Consolaro, A
Verazza, S
Bracciolini, G
Rosina, S
Pignataro, R
Civino, A
Martini, A
Ravelli, A
author_sort Negro, G
collection PubMed
description
format Online
Article
Text
id pubmed-4043642
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40436422014-06-17 PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients Negro, G Consolaro, A Verazza, S Bracciolini, G Rosina, S Pignataro, R Civino, A Martini, A Ravelli, A Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4043642/ http://dx.doi.org/10.1186/1546-0096-11-S2-P155 Text en Copyright © 2013 Negro et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Negro, G
Consolaro, A
Verazza, S
Bracciolini, G
Rosina, S
Pignataro, R
Civino, A
Martini, A
Ravelli, A
PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients
title PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients
title_full PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients
title_fullStr PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients
title_full_unstemmed PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients
title_short PReS-FINAL-2143: Treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients
title_sort pres-final-2143: treat-to-target strategy in juvenile idiopathic arthritis: experience in 175 newly-diagnosed patients
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043642/
http://dx.doi.org/10.1186/1546-0096-11-S2-P155
work_keys_str_mv AT negrog presfinal2143treattotargetstrategyinjuvenileidiopathicarthritisexperiencein175newlydiagnosedpatients
AT consolaroa presfinal2143treattotargetstrategyinjuvenileidiopathicarthritisexperiencein175newlydiagnosedpatients
AT verazzas presfinal2143treattotargetstrategyinjuvenileidiopathicarthritisexperiencein175newlydiagnosedpatients
AT bracciolinig presfinal2143treattotargetstrategyinjuvenileidiopathicarthritisexperiencein175newlydiagnosedpatients
AT rosinas presfinal2143treattotargetstrategyinjuvenileidiopathicarthritisexperiencein175newlydiagnosedpatients
AT pignataror presfinal2143treattotargetstrategyinjuvenileidiopathicarthritisexperiencein175newlydiagnosedpatients
AT civinoa presfinal2143treattotargetstrategyinjuvenileidiopathicarthritisexperiencein175newlydiagnosedpatients
AT martinia presfinal2143treattotargetstrategyinjuvenileidiopathicarthritisexperiencein175newlydiagnosedpatients
AT ravellia presfinal2143treattotargetstrategyinjuvenileidiopathicarthritisexperiencein175newlydiagnosedpatients